Global Custom Antibody Service Market Size Was Worth USD 393 million in 2021 and Is Projected to Grow to USD 652 million by 2026

November 02, 2021, New York, USA -

Custom Antibody Services: Introduction

Antibodies are the host proteins that are produced by the human body in response to the introduction of foreign molecules and organisms into the body. Although these foreign substances or foreign bodies are known as antigens, they are recognized in the body's immune system by the individual. Researchers from all over the globe are engaged in different research projects that focus on using this natural process of the human body of making custom antibodies to fight antigens that represent specific diseases or health issues.

It is important to remember that custom antibodies are able to offer greater specificity and selectiveness than conventionally made antibodies. Additionally, the process of creating these antibodies is much simpler as compared to other antibodies. In the end, the demand for custom antibodies is growing each day in various types of research.

Therefore, a noticeable increase in research of biology and life sciences has led to a rise in demand for custom-made antibodies. This is assisting in the growth of the world market for custom antibodies at an increasing rate. In addition, this market of custom antibodies is expected to take benefit of the increasing numbers of partnerships and collaborations with industry leaders and academic institutions.

The Global Custom Antibody Services Market Forecast: 

The global custom antibody service market was USD 393 million in 2021, and It is expected to reach USD 652 million by 2026. The market will grow at a CAGR of 10.6% during the forecast period.

Whenever foreign bodies or molecules enter the body, the body produces antibodies (host protein) as a reaction. These foreign molecules or bodies are known as antigens and are analyzed by the immune system of the body. This natural reaction of your body's immune system to generate antibodies can be utilized to create customized antibodies that target specific diseases or conditions.

Custom antibodies have greater specificity and selectivity than regular antibodies. Furthermore, they are fairly simple to make when compared to other antibodies, making them a highly sought-after for all kinds of research. Many factors, including the growing research and development in the life sciences and biology and the growing collaboration between academic centers as well as the industry's leaders, are expected to play an important role in the development of the market for custom antibody production during the forecast time.

Market Trend and Dynamics of the Global Custom Antibody Services Market:

Driver: Increasing research activities and funding  

The R&D sector has traditionally remained high in the capital due to the long development time frames as well as approval cycle. R&D investments hold a top spot in global expenditure. Governments are aware of R&D as a vital investment to advance a nation's development as well as international competitiveness and public benefits. This is why R&D spending and funding have seen an increasing trend over the past few years. According to R&D Magazine (2020), In 2021, approximately the amount of USD 2.5 trillion is expected to be invested into R&D laboratories, industries, as well as government labs, and academic research centers in more than 100 nations.

The R&D expenditure all over the world experienced an abrupt change in the market because of the sudden emergence from the pandemic COVID-19. Different countries saw a huge reduction in their R&D spending in the year 2020. However, China witnessed a historic R&D investment of 10.0% of its annual. The R&D share in the Top 10 nations in 2020 was 79.2 %. This amount is predicted to be the same by 2021.

The current demand for effective treatments that are less prone to adverse effects has resulted in an increased focus on research and the development of biopharmaceuticals. The R&D industry in the pharmaceutical sector is responsible for around 80 percent of all research and development expenditures for the Life Sciences sector. The largest pharmaceutical companies, like Merck KGaA (German, as well as F. Hoffmann-La Roche Ltd. (Switzerland), account for a large portion of the biopharmaceutical industry's R&D investment, which is around USD 50 billion per year.

Additionally, funding from different organizations for genome-related projects is increasing research in the area of genomics. The increase in research activity and the accessibility of funds is expected to increase the overall consumption and purchase of antibodies, increasing the size of the market for custom antibodies.

The Key Market Segmentation of the Global Custom Antibody Services Market: 

Global Custom Antibody Services Market can be divided into Service, Types, Source, Research Area, End-User and Geographical landscapes, etc. 

Custom Antibody Services Market Segmentation By Service:

• Antibody Development
• Antibody Production & Purification
• Antibody Fragmentation & Labeling

Custom Antibody Services Market Segmentation By Type:

• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Other Custom Antibodies

Custom Antibody Services Market Segmentation By Source:

• Mice
• Rabbits
• Other Sources

Custom Antibody Services Market Segmentation By Research Area:

• Oncology
• Infectious Diseases
• Neurobiology
• Stem Cells
• Immunology
• Cardiovascular Disease
• Other Research Areas

Custom Antibody Services Market Segmentation By End-User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Custom Antibody Services Market Segmentation By Geographical Landscape:

• North America
• Europe
• Asia Pacific
• South America
• The Middle East and Africa

The Covid-19 Impact Analysis:

Currently, for the treatment of COVID-19, there are various types of vaccines, and antiviral drugs have been approved or being developed. And many patients have been receiving treatment according to their symptoms. As per the information provided by WHO, only 9 Vaccine candidates have been approved out of 65 vaccine candidates. Still, a Total of 56 vaccine candidates have been going through development.

At the forefront of the COVID-19 outbreak, a large number of researchers around the world are engaged in research on the virus SARS-CoV-2, which is the virus that causes COVID-19. In both therapeutics and vaccines, the produced antibodies are evaluated for their effectiveness in neutralizing the virus that is targeted.

The use of custom-made antibody services has grown in the creation of COVID-19 vaccines. The companies that operate in the custom-antibody services market, which include Thermo Fisher Scientific (US) and Abcam plc (US) had an adverse impact on their operations during Q1 and Q2 2020 due to the temporary shut down of their labs.

But as the lockdown, restrictions began to be lifted, and research labs across the globe began reopening. The majority of service providers emphasized actions to assist the vital work of their customers who are involved in COVID-19, such as providing a variety of high-quality COVID-19-related research tools, shifting R&D resources for the development of crucial products for SARS-Cov-2, and enhancing the flexibility of supply chains and manufacturing to accommodate the increasing demand for the existing products that are used in research on COVID-19 and SARS, and establishing discussions and collaborations with colleagues across China, the UK, and the US, that focus on SARS-CoV-2 diagnostics as well as vaccines, and drugs creation.